Subacute inflammatory demyelinating polyneuropathy

disease
On this page

Also known as SIDPsubacute inflammatory demyelinating polyradiculoneuropathy

Summary

Subacute inflammatory demyelinating polyneuropathy (MONDO:0016102) is a disease. A subtype of demyelinating polyneuropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide)
  • Phenotypes (HPO): 40

Clinical features

Signs & symptoms

Clinical features (HPO)

40 HPO clinical features (Orphanet curated; top 40 by frequency):

HPO IDTermFrequency
HP:0000762Decreased nerve conduction velocityVery frequent (80-99%)
HP:0001324Muscle weaknessVery frequent (80-99%)
HP:0002922Increased CSF protein concentrationVery frequent (80-99%)
HP:0003431Decreased motor nerve conduction velocityVery frequent (80-99%)
HP:0007377Abnormality of somatosensory evoked potentialsVery frequent (80-99%)
HP:0001284AreflexiaFrequent (30-79%)
HP:0001288Gait disturbanceFrequent (30-79%)
HP:0001974LeukocytosisFrequent (30-79%)
HP:0002359Frequent fallsFrequent (30-79%)
HP:0003447Axonal lossFrequent (30-79%)
HP:0003474Somatic sensory dysfunctionFrequent (30-79%)
HP:0003551Difficulty climbing stairsFrequent (30-79%)
HP:0003565Elevated erythrocyte sedimentation rateFrequent (30-79%)
HP:0004302Functional motor deficitFrequent (30-79%)
HP:0006881Diffuse peripheral demyelinationFrequent (30-79%)
HP:0007078Decreased amplitude of sensory action potentialsFrequent (30-79%)
HP:0007141Sensorimotor neuropathyFrequent (30-79%)
HP:0007220Demyelinating motor neuropathyFrequent (30-79%)
HP:0007262Symmetric peripheral demyelinationFrequent (30-79%)
HP:0011096Peripheral demyelinationFrequent (30-79%)
HP:0012531PainFrequent (30-79%)
HP:0001266ChoreoathetosisOccasional (5-29%)
HP:0001337TremorOccasional (5-29%)
HP:0001430Abnormality of the calf musculatureOccasional (5-29%)
HP:0002403Positive Romberg signOccasional (5-29%)
HP:0002460Distal muscle weaknessOccasional (5-29%)
HP:0002936Distal sensory impairmentOccasional (5-29%)
HP:0003237Increased circulating IgG levelOccasional (5-29%)
HP:0003376Steppage gaitOccasional (5-29%)
HP:0003448Decreased sensory nerve conduction velocityOccasional (5-29%)
HP:0006376Limited elbow flexionOccasional (5-29%)
HP:0006844Absent patellar reflexesOccasional (5-29%)
HP:0007230Decreased distal sensory nerve action potentialOccasional (5-29%)
HP:0008800Limited hip movementOccasional (5-29%)
HP:0010505Limitation of movement at anklesOccasional (5-29%)
HP:0012078Motor conduction blockOccasional (5-29%)
HP:0032169Severe infectionOccasional (5-29%)
HP:0002086Abnormality of the respiratory systemVery rare (<1-4%)
HP:0002270Abnormality of the autonomic nervous systemVery rare (<1-4%)
HP:0006824Cranial nerve paralysisVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical namesubacute inflammatory demyelinating polyneuropathy
Mondo IDMONDO:0016102
Orphanet206594
ICD-111692167541
SNOMED CT277189006
UMLSC0456517
MedGen629329
GARD0020355
Is cancer (heuristic)no

Also known as: SIDP · subacute inflammatory demyelinating polyradiculoneuropathy

Disease family

This is a subtype of demyelinating polyneuropathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorderperipheral nervous system disorderperipheral neuropathypolyneuropathydemyelinating polyneuropathysubacute inflammatory demyelinating polyneuropathy

Related subtypes (1): chronic inflammatory demyelinating polyradiculoneuropathy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.